Remdesivir
Remdesivir is an overpriced, sometimes harmful and mostly ineffective patented medication being promoted by liberals to treat coronavirus. It is administered intravenously and thus requires a very costly 5-day stay in a hospital, in addition to thousands of dollars per patient charged by a pharmaceutical company for the medication itself.[1] Although remdesivir was heavily touted by Anthony Fauci and other liberals, on Oct. 16, 2020 CNN admitted, "Big global study finds remdesivir doesn't help Covid-19 patients."[2] “This will be the standard of care” for COVID-19, Fauci declared in early 2020.[3]
As of November 19, 2020, "A World Health Organization panel is now recommending against the use of the antiviral remdesivir in hospitalized Covid-19 patients, saying there is no evidence that the drug — which U.S. regulators have approved for the treatment of the coronavirus — improves mortality."[4]
Daniel Horowitz explained in a detailed article that "Remdesivir is the greatest scandal of the pandemic."[5]
Remdesivir depends on a very specific enzyme and thus might not work if its conformation is slightly changed. The overall costs, including hospital expenses, for administering remdesivir to a patient can be as high as $20,000 for a full treatment. But hospitals receive special financial incentives to administer remdesivir despite its ineffectiveness.[6]
In contrast, the superior and much less expensive hydroxychloroquine changes milieu in the cell and makes the pH unfavorable, such that mutations are not likely to render HCQ ineffective.
Some suspect that overuse of remdesivir may result in viral resistance to the drug, which is a strong reason to prefer hydroxychloroquine over remdesivir.
The Remdesivir data from the Medicare Tracking System reveals of the 7,960 beneficiaries prescribed Remdesivir for Covid-19, 2,058 died. That is 25.9%.
46% of people died within 14 days of the Remdesivir Treatment. The Remdesivir Treatment was established in U.S. Hospitals at the direction of Dr. Anthony Fauci. Serious adverse events were reported in 131 of the 532 patients who received Remdesivir. That is 24.6%.[7]
References
- ↑ https://www.cbsnews.com/news/gilead-coronavirus-treatment-remdesivir-private-insurance-cost/
- ↑ https://www.cnn.com/2020/10/15/health/remdesivir-covid-who-trial-mortality/index.html
- ↑ https://www.healio.com/news/infectious-disease/20200429/fauci-on-remdesivir-for-covid19-this-will-be-the-standard-of-care
- ↑ https://www.statnews.com/2020/11/19/who-recommends-against-remdesivir-covid-19/
- ↑ https://www.theblaze.com/op-ed/horowitz-remdesivir-is-the-greatest-scandal-of-the-pandemic
- ↑ "CMS in October announced interim add-on payments for COVID-19 treatments including remdesivir through the HHS-declared public health emergency. The declaration next expires in January, though stakeholders think it’s likely the emergency will be renewed." [1]
- ↑ https://theconservativetreehouse.com/blog/2021/10/01/attorney-thomas-renz-releases-medicare-and-pfizer-whistleblower-data-vaccine-related-injuries-and-deaths-far-more-widespread-than-reported/
